Evaluation of commercial enzyme-linked immunosorbent assays to identify psychedelic phenethylamines

Journal of Analytical Toxicology

Volumn 35, Issue 7, 2011, Pages 444-451

  Kerrigan, Sarah ^a   Mellon, Monica Brady ^a   Banuelos, Stephanie ^a,b   Arndt, Crystal ^a,c  

^a SAM HOUSTON STATE UNIVERSITY   (United States)

^b Texas Department of Public Safety Crime Laboratory   (United States)

^c Harris County Institute of Forensic Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,5 DIMETHOXY 4 BROMOPHENETHYLAMINE; 2,5 DIMETHOXY 4 ETHYLTHIOPHENETHYLAMINE; 2,5 DIMETHOXY 4 IODOPHENETHYLAMINE; 2,5 DIMETHOXY 4 ISOPROPYLTHIOPHENETHYLAMINE; 2,5 DIMETHOXY 4 METHYLAMPHETAMINE; 2,5 DIMETHOXY 4 PROPYLTHIOPHENETHYLAMINE; 2,5 DIMETHOXYPHENETHYLAMINE; 4 ETHYL 2,5 DIMETHOXYAMPHETAMINE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 4 METHYLTHIOAMPHETAMINE; BROLAMFETAMINE; METHAMPHETAMINE; PHENETHYLAMINE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; CHROMATOGRAPHY; CROSS REACTION; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; FORENSIC TOXICOLOGY; HUMAN; URINALYSIS; URINE LEVEL;

EID: 80052623507     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/anatox/35.7.444     Document Type: Article

References (33)

1. A. Shulgin and A. Shulgin. Phenethylamines I Have Known and Loved (PiHKAL): A Chemical Love Story. Transform Press, Berkeley, CA, 1991.
2. M.D. Cole, C. Lea, and N. Oxley. 4-Bromo-2,5-dimethoxyphenethylamine (2C-B): a review of the public domain literature. Sci. Justice 42: 223-224 (2002).
3. The Vaults of Erowid. Psychoactive Vaults. www.erowid.org (accessed April 2010).
4. Drug Enforcement Administration Drugs and Chemicals of Concern. http://www.deadiversion.usdoj.gov.
5. N. Khorana, M.R. Pullagurla, M. Dukat, R.Young and R.A. Glennon. Stimulus effects of three sulfur-containing psychoactive agents. Pharmacol. Biochem. Behav. 78: 821-826 (2004).
6. D.S. Theobald, S. Fehn, and H.H. Maurer. New designer drug, 2,5-dimethoxy-4-propylthio-β-phenethylamine (2C-T-7) studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry. J. Mass Spectrom. 40: 105-116 (2005).
7. M. Balíková. Nonfatal and fatal DOB (2,5-dimethoxy-4-bromoamphetamine) overdose. Forensic Sci. Int. 153: 85-91 (2005).
8. X. Huang, D. Marona-Lewicka, and D.E. Nichols. p-Methylthioamphetamine is a potent new non-neurotoxic serotonin releasing agent. Eur. J. Pharmacol. 229: 31-38 (1992).
9. R.C. Baselt. Disposition of Toxic Drugs and Chemicals in Man, 7th ed. Biomedical Publications, Foster City, CA, 2004, pp 731-732.
10. R.F. Staack and H.H. Maurer. Metabolism of designer drugs of abuse. Curr. Drug Metab. 6: 259-274 (2005).
11. C. Acuña-Castillo, C.Villalobos, P.R. Moya, P. Sáez, B.K. Cassels, and J.P. Huidobro-Toro. Differences in potency and efficacy of a series of phenylisopropylamine/phenylethylamine pairs at 5-HT2A and 5-HT2C receptors. Br. J. Pharmacol. 136: 510-519 (2002).
12. National Drug Intelligence Center: U.S. Department of Justice. Information Bulletin. 2C-B (Nexus) reappears on the club drug scene.
13. European Monitoring Centre for Drugs and Drug Addiction (2004). Report on the risk assessment of 2C-I, 2C-T-2, and 2C-T-7 in the framework of the joint action on new synthetic drugs.
14. B. Curtis, P. Kemp, L. Harty, C. Choi, and D. Christensen. Postmortem identification and quantitation of 2,5-dimethoxy-4-npropylthiophenethylamine using GC.MSD and GC.NPD. J. Anal. Toxicol. 27: 493-498 (2003).
15. S.P. Elliot. Fatal poisoning with a new phenethylamine: 4-methylthioamphetamine (4-MTA). J. Anal. Toxicol. 24: 85-89 (2000).
16. E.A. De Letter, V.A. Coopman, J.A. Cordonnier, and M.H. Piette. One fatal and seven non-fatal cases of 4-methylthioamphetamine (4-MTA) intoxication: clinico-pathological findings. Int. J. Legal Med. 114: 352-356 (2001).
17. T. Dacaestecker, E. De Letter, K. Clauwert, M. Bouche, W. Lambert, J. Van Bocxlaer, M. Piette, E. Van den Eeckhout, C. Van Peteghem, and A. De Leenheer. Fatal 4-MTA intoxication: development of a liquid chromatographic-tandem mass spectrometric assay for multiple matrices. J. Anal. Toxicol. 25: 705-710 (2001).
18. P. Suttijitpaisal and K. Ratanabanangkoon. Immunoassays of amphetamines: immunogen structure vs antibody specificity. Asian Pac. J. Allergy Immunol. 10: 159-164 (1992).
19. L.J. Farrell, S. Kerrigan, and B.K. Logan. Recommendations for toxicological investigation of drug impaired driving. J. Forensic Sci. 52: 1214-1218 (2007).
20. M. Miyajima, T. Matsumoto, and S. Ito. 2C-T-4 intoxication: acute psychosis caused by a designer drug. Psychiatry Clin. Neurosci. 62: 243 (2008).
21. J.T. Cody and R. Schwarzhoff. Fluorescence polarization immunoassay detection of amphetamine, methamphetamine, and illicit amphetamine analogues. J. Anal. Toxicol. 17: 23-33 (1993).
22. T. Kanamori, H. Inoue, Y. Iwata, Y. Ohmae, and T. Kishi. In vivo metabolism of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in the rat: identification of urinary metabolites. J. Anal. Toxicol. 26: 61-66 (2002).
23. T. Kanamori, K. Tsujikawa,Y. Ohmae,Y. Iwata, H. Inoue,Y. Inouye, and T. Kishi. Excretory profile of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rat. J. Health Sci. 49: 166-169 (2003).
24. L.-C. Lin, J.-T. Liu, S.-H. Chou, and C.-H. Lin. Identification of 2,5-dimethoxy-4-ethylthiophenethylamine and its metabolites in the urine of rats by gas chromatography-mass spectrometry. J. Chromatogr. B 798: 241-247 (2003).
25. A.H. Ewald, F.T. Peters, M. Weise, and H.H. Maurer. Studies on the metabolism and toxicological detection of the designer drug 4-methylthioamphetamine (4-MTA) in human urine using gas chromatography-mass spectrometry. J. Chromatogr. B 824: 123-131 (2005).
26. D.S. Theobald, R.F. Staack, M. Puetz, and H.H. Maurer. New designer drug 2,5-dimethoxy-4-ethylthio-βphenethylamine (2C-T-2): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry. J.Mass Spectrom. 40: 1157-1172 (2005).
27. A.H. Ewald, G. Fritschi, W.-R. Bork, and H.H. Maurer. Designer drugs 2,5-dimethoxy-4-bromo-amphetamine (DOB) and 2,5-dimethoxy-4-bromo-methamphetamine (MDOB): studies on their metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques. J. Mass Spectrom. 41: 487-498 (2006).
28. D.S. Theobald, M. Putz, E. Schneider, and H.H. Maurer. New designer drug 4-iodo-2,5-dimethoxy-β-phenethylamine (2C-I): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric and capillary electrophoretic/mass spectrometric techniques. J.Mass Spectrom. 41: 872-886 (2006).
29. A.H. Ewald, G. Fritschi, and H.H. Maurer. Metabolism and toxicological detection of the designer drug 4-iodo-2,5-dimethoxyamphetamine (DOI) in rat urine using gas chromatography-mass spectrometry. J. Chromatogr. B 857: 170-174 (2007).
30. D.S. Theobald, G. Fritschi, and H.H. Maurer. Studies on the toxicological detection of the designer drug 4-bromo-2,5-dimethoxy-βphenethylamine (2C-B) in rat urine using gas chromatography-mass spectrometry. J. Chromatogr. B 846: 374-377 (2007).
31. A.H. Ewald, M. Puetz, and H.H. Maurer. Designer drug 2,5-dimethoxy-4-methyl-amphetamine (DOM, STP): involvement of the cytochrome P450 isoenzymes in formation of its main metabolite and detection of the latter in rat urine as proof of a drug intake using gas chromatography-mass spectrometry. J. Chromatogr. B 862: 252-256 (2008).
32. M. Rohanová, T. Páleníček, and M. Balíková. Disposition of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) and its metabolite 4-bromo-2-hydroxy-5-methoxyphenethylamine in rats after subcutaneous administration. Toxicol. Lett. 178: 29-36 (2008).
33. L.G. Apollonio, I.R. Whittall, D.J. Pianca, J.M. Kyd, and W.A. Maher. Matrix effect and cross-reactivity of select amphetamine-type substances, designer analogues, and putrefactive amines using the Bio-Quant Direct ELISA presumptive assays for amphetamine and methamphetamine. J. Anal. Toxicol. 31: 208-213 (2007).